✦ LIBER ✦

Poster group 2 – Haemopoietic stem cell transplantation

Book ID: 110037594
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 157 KB
Volume: 5
Category: Article
ISSN: 1466-4879
DOI: 10.1038/sj.gene.6364081

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VDRL screening and haemopoietic stem cel

VDRL screening and haemopoietic stem cell transplantation

✍ Au, W Y; Lie, A K W; Cheng, V C C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Haemopoietic stem cell transplantation f

Haemopoietic stem cell transplantation for acquired cytopenias

✍ Jill Hows 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 237 KB

HAEMOPOIETIC STEM CELL TRANSPLANTATION F

HAEMOPOIETIC STEM CELL TRANSPLANTATION FROM UNRELATED DONORS

✍ Helen E. Heslop 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Haemopoietic reconstitution by donor-der

Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation

✍ Marco Mielcarek; Eileen Bryant; Michael Loken; Beverly Torok-Storb; Rainer Storb 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Human cytomegalovirus-specific immunity

Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation

✍ Maher K Gandhi; Mark R Wills; J.G Patrick Sissons; Andrew J Carmichael 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 102 KB

The herpesvirus Human Cytomegalovirus (HCMV) is an important opportunistic infection in recipients of allogeneic haemopoietic stem cell transplants, in whom HCMV-specific CD8+ and CD4+ T-cell responses are impaired. The nature of the HCMV-specific T-cell response in healthy virus carriers has been c

Advances in the genomics of allogeneic h

Advances in the genomics of allogeneic haemopoietic stem cell transplantation

✍ Charles G. Mullighan; Peter G. Bardy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

## Abstract Allogeneic haemopoietic stem cell transplantation is curative for many patients with haematologic disorders. Despite advances in supportive care, complications such as graft‐versus‐host disease (GVHD) and infection remain important causes of morbidity and mortality after transplantation